Summary

The COVID-19 Diagnostics Market is set for steady growth, with a projected valuation of USD 4.6 billion in 2026, reaching USD 6.69 billion by 2033, growing at a CAGR of 5.5% during the forecast period. The market’s expansion is driven by rising demand for rapid, accurate, and accessible testing solutions across healthcare settings worldwide.

Market Overview

COVID-19 diagnostics have become essential tools in the global fight against the pandemic. Accurate and timely detection of the virus is critical for controlling outbreaks, reducing transmission, and enabling effective treatment. Technological innovations, coupled with increased testing initiatives, are reshaping the landscape for diagnostics providers, ensuring better coverage in both developed and emerging markets.

Polymerase Chain Reaction (PCR) testing remains the gold standard due to its precision and reliability. Complementary diagnostic technologies, such as enzyme-linked immunosorbent assay (ELISA) and lateral flow immunoassay (LFIA), are widely used for rapid detection, particularly in point-of-care and home-testing applications. Integration with digital reporting systems has further enhanced testing efficiency, enabling real-time monitoring of infection trends.

Key Market Drivers

Several factors are fueling the growth of the COVID-19 diagnostics market:

• Need for Early Detection: Rapid identification of COVID-19 cases is vital for controlling virus spread and preventing hospital overload.

• Technological Advancements: The development of automated PCR platforms, high-sensitivity antigen tests, and multiplex assays enhances diagnostic speed and accuracy.

• Government Support: Public health initiatives, funding for testing infrastructure, and emergency regulatory approvals have accelerated market adoption.

• Rising Home Testing: The increasing availability of self-testing kits provides convenience and reduces the strain on healthcare facilities.

Business Opportunities

The market offers promising opportunities for diagnostics manufacturers and service providers. The growing adoption of point-of-care testing and home-based diagnostics provides avenues for innovative product development. Companies can expand their reach through collaborations and strategic partnerships, focusing on developing next-generation diagnostics that meet both urban and rural healthcare needs. Additionally, leveraging AI and IoT-enabled diagnostic platforms can improve predictive analysis and streamline reporting for healthcare providers.

Regional Insights

North America leads the COVID-19 diagnostics market, driven by advanced healthcare infrastructure, high testing rates, and strong regulatory support. Europe follows with widespread mass testing campaigns and substantial public health investments. The Asia Pacific region is projected to experience the fastest growth, fueled by rising awareness, increasing healthcare expenditure, and expanding diagnostic networks in countries like China, India, and Japan. Latin America and the Middle East & Africa are witnessing gradual growth, supported by initiatives to strengthen testing capacity and healthcare access.

Key Players

Prominent companies operating in the global COVID-19 diagnostics market include:

• Abbott Laboratories

• Thermo Fisher Scientific Inc.

• Roche Diagnostics (F. Hoffmann-La Roche Ltd.)

• Siemens Healthineers AG

• Danaher Corporation (including Beckman Coulter)

• Bio-Rad Laboratories, Inc.

• QuidelOrtho Corporation

• Becton, Dickinson and Company (BD)

• PerkinElmer, Inc.

• Hologic, Inc.

• Cepheid (Danaher Group)

• Mesa Biotech (now part of Thermo Fisher)

• Abbott Rapid Diagnostics (Alere)

• Seegene, Inc.

• Meridian Bioscience, Inc.

Market Segmentation

By Product

• Instruments

• Reagents & Kits

By Technology

• Polymerase Chain Reaction (PCR)

• Enzyme-Linked Immunosorbent Assay (ELISA)

• Lateral Flow Immunoassay (LFIA)

• Others

By Sample Type

• Oropharyngeal & Nasopharyngeal Swabs

• Nasal Swabs

• Blood

By Setting

• Lab-based

• Point of Care

By End-user

• Hospitals & Clinics

• Laboratories & Diagnostic Centers

• Home Testing

• Others

By Geography

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global COVID-19 Diagnostics Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2026
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. COVID-19 Impact Analysis
2.5. Porter's Fiver Forces Analysis
2.6. Impact of Russia-Ukraine Conflict
2.7. PESTLE Analysis
2.8. Regulatory Analysis
2.9. Price Trend Analysis
2.9.1. Current Prices and Future Projections, 2025-2033
2.9.2. Price Impact Factors
3. Global COVID-19 Diagnostics Market Outlook, 2020-2033
3.1. Global COVID-19 Diagnostics Market Outlook, by Product, Value (US$ Mn), 2020-2033
3.1.1. Instruments
3.1.2. Reagents & Kits
3.2. Global COVID-19 Diagnostics Market Outlook, by Technology, Value (US$ Mn), 2020-2033
3.2.1. Polymerase Chain Reaction (PCR)
3.2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
3.2.3. Lateral Flow Immunoassay (LFIA)
3.2.4. Others
3.3. Global COVID-19 Diagnostics Market Outlook, by Sample Type, Value (US$ Mn), 2020-2033
3.3.1. Oropharyngeal & Nasopharyngeal Swabs
3.3.2. Nasal Swabs
3.3.3. Blood
3.4. Global COVID-19 Diagnostics Market Outlook, by Setting, Value (US$ Mn), 2020-2033
3.4.1. Lab-based
3.4.2. Point of Care
3.5. Global COVID-19 Diagnostics Market Outlook, by End-user, Value (US$ Mn), 2020-2033
3.5.1. Hospitals & Clinics
3.5.2. Laboratories & Diagnostic Centers
3.5.3. Home Testing
3.5.4. Others
3.6. Global COVID-19 Diagnostics Market Outlook, by Region, Value (US$ Mn), 2020-2033
3.6.1. North America
3.6.2. Europe
3.6.3. Asia Pacific
3.6.4. Latin America
3.6.5. Middle East & Africa
4. North America COVID-19 Diagnostics Market Outlook, 2020-2033
4.1. North America COVID-19 Diagnostics Market Outlook, by Product, Value (US$ Mn), 2020-2033
4.1.1. Instruments
4.1.2. Reagents & Kits
4.2. North America COVID-19 Diagnostics Market Outlook, by Technology, Value (US$ Mn), 2020-2033
4.2.1. Polymerase Chain Reaction (PCR)
4.2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
4.2.3. Lateral Flow Immunoassay (LFIA)
4.2.4. Others
4.3. North America COVID-19 Diagnostics Market Outlook, by Sample Type, Value (US$ Mn), 2020-2033
4.3.1. Oropharyngeal & Nasopharyngeal Swabs
4.3.2. Nasal Swabs
4.3.3. Blood
4.4. North America COVID-19 Diagnostics Market Outlook, by Setting, Value (US$ Mn), 2020-2033
4.4.1. Lab-based
4.4.2. Point of Care
4.5. North America COVID-19 Diagnostics Market Outlook, by End-user, Value (US$ Mn), 2020-2033
4.5.1. Hospitals & Clinics
4.5.2. Laboratories & Diagnostic Centers
4.5.3. Home Testing
4.5.4. Others
4.6. North America COVID-19 Diagnostics Market Outlook, by Country, Value (US$ Mn), 2020-2033
4.6.1. U.S. COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
4.6.2. U.S. COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
4.6.3. U.S. COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
4.6.4. U.S. COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
4.6.5. U.S. COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
4.6.6. Canada COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
4.6.7. Canada COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
4.6.8. Canada COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
4.6.9. Canada COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
4.6.10. Canada COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
4.7. BPS Analysis/Market Attractiveness Analysis
5. Europe COVID-19 Diagnostics Market Outlook, 2020-2033
5.1. Europe COVID-19 Diagnostics Market Outlook, by Product, Value (US$ Mn), 2020-2033
5.1.1. Instruments
5.1.2. Reagents & Kits
5.2. Europe COVID-19 Diagnostics Market Outlook, by Technology, Value (US$ Mn), 2020-2033
5.2.1. Polymerase Chain Reaction (PCR)
5.2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
5.2.3. Lateral Flow Immunoassay (LFIA)
5.2.4. Others
5.3. Europe COVID-19 Diagnostics Market Outlook, by Sample Type, Value (US$ Mn), 2020-2033
5.3.1. Oropharyngeal & Nasopharyngeal Swabs
5.3.2. Nasal Swabs
5.3.3. Blood
5.4. Europe COVID-19 Diagnostics Market Outlook, by Setting, Value (US$ Mn), 2020-2033
5.4.1. Lab-based
5.4.2. Point of Care
5.5. Europe COVID-19 Diagnostics Market Outlook, by End-user, Value (US$ Mn), 2020-2033
5.5.1. Hospitals & Clinics
5.5.2. Laboratories & Diagnostic Centers
5.5.3. Home Testing
5.5.4. Others
5.6. Europe COVID-19 Diagnostics Market Outlook, by Country, Value (US$ Mn), 2020-2033
5.6.1. Germany COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
5.6.2. Germany COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
5.6.3. Germany COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
5.6.4. Germany COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
5.6.5. Germany COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
5.6.6. Italy COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
5.6.7. Italy COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
5.6.8. Italy COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
5.6.9. Italy COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
5.6.10. Italy COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
5.6.11. France COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
5.6.12. France COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
5.6.13. France COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
5.6.14. France COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
5.6.15. France COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
5.6.16. U.K. COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
5.6.17. U.K. COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
5.6.18. U.K. COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
5.6.19. U.K. COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
5.6.20. U.K. COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
5.6.21. Spain COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
5.6.22. Spain COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
5.6.23. Spain COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
5.6.24. Spain COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
5.6.25. Spain COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
5.6.26. Russia COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
5.6.27. Russia COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
5.6.28. Russia COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
5.6.29. Russia COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
5.6.30. Russia COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
5.6.31. Rest of Europe COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
5.6.32. Rest of Europe COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
5.6.33. Rest of Europe COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
5.6.34. Rest of Europe COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
5.6.35. Rest of Europe COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
5.7. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific COVID-19 Diagnostics Market Outlook, 2020-2033
6.1. Asia Pacific COVID-19 Diagnostics Market Outlook, by Product, Value (US$ Mn), 2020-2033
6.1.1. Instruments
6.1.2. Reagents & Kits
6.2. Asia Pacific COVID-19 Diagnostics Market Outlook, by Technology, Value (US$ Mn), 2020-2033
6.2.1. Polymerase Chain Reaction (PCR)
6.2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
6.2.3. Lateral Flow Immunoassay (LFIA)
6.2.4. Others
6.3. Asia Pacific COVID-19 Diagnostics Market Outlook, by Sample Type, Value (US$ Mn), 2020-2033
6.3.1. Oropharyngeal & Nasopharyngeal Swabs
6.3.2. Nasal Swabs
6.3.3. Blood
6.4. Asia Pacific COVID-19 Diagnostics Market Outlook, by Setting, Value (US$ Mn), 2020-2033
6.4.1. Lab-based
6.4.2. Point of Care
6.5. Asia Pacific COVID-19 Diagnostics Market Outlook, by End-user, Value (US$ Mn), 2020-2033
6.5.1. Hospitals & Clinics
6.5.2. Laboratories & Diagnostic Centers
6.5.3. Home Testing
6.5.4. Others
6.6. Asia Pacific COVID-19 Diagnostics Market Outlook, by Country, Value (US$ Mn), 2020-2033
6.6.1. China COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
6.6.2. China COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
6.6.3. China COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
6.6.4. China COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
6.6.5. China COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
6.6.6. Japan COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
6.6.7. Japan COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
6.6.8. Japan COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
6.6.9. Japan COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
6.6.10. Japan COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
6.6.11. South Korea COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
6.6.12. South Korea COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
6.6.13. South Korea COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
6.6.14. South Korea COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
6.6.15. South Korea COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
6.6.16. India COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
6.6.17. India COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
6.6.18. India COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
6.6.19. India COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
6.6.20. India COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
6.6.21. Southeast Asia COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
6.6.22. Southeast Asia COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
6.6.23. Southeast Asia COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
6.6.24. Southeast Asia COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
6.6.25. Southeast Asia COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
6.6.26. Rest of SAO COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
6.6.27. Rest of SAO COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
6.6.28. Rest of SAO COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
6.6.29. Rest of SAO COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
6.6.30. Rest of SAO COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
6.7. BPS Analysis/Market Attractiveness Analysis
7. Latin America COVID-19 Diagnostics Market Outlook, 2020-2033
7.1. Latin America COVID-19 Diagnostics Market Outlook, by Product, Value (US$ Mn), 2020-2033
7.1.1. Instruments
7.1.2. Reagents & Kits
7.2. Latin America COVID-19 Diagnostics Market Outlook, by Technology, Value (US$ Mn), 2020-2033
7.2.1. Polymerase Chain Reaction (PCR)
7.2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
7.2.3. Lateral Flow Immunoassay (LFIA)
7.2.4. Others
7.3. Latin America COVID-19 Diagnostics Market Outlook, by Sample Type, Value (US$ Mn), 2020-2033
7.3.1. Oropharyngeal & Nasopharyngeal Swabs
7.3.2. Nasal Swabs
7.3.3. Blood
7.4. Latin America COVID-19 Diagnostics Market Outlook, by Setting, Value (US$ Mn), 2020-2033
7.4.1. Lab-based
7.4.2. Point of Care
7.5. Latin America COVID-19 Diagnostics Market Outlook, by End-user, Value (US$ Mn), 2020-2033
7.5.1. Hospitals & Clinics
7.5.2. Laboratories & Diagnostic Centers
7.5.3. Home Testing
7.5.4. Others
7.6. Latin America COVID-19 Diagnostics Market Outlook, by Country, Value (US$ Mn), 2020-2033
7.6.1. Brazil COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
7.6.2. Brazil COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
7.6.3. Brazil COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
7.6.4. Brazil COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
7.6.5. Brazil COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
7.6.6. Mexico COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
7.6.7. Mexico COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
7.6.8. Mexico COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
7.6.9. Mexico COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
7.6.10. Mexico COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
7.6.11. Argentina COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
7.6.12. Argentina COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
7.6.13. Argentina COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
7.6.14. Argentina COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
7.6.15. Argentina COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
7.6.16. Rest of LATAM COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
7.6.17. Rest of LATAM COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
7.6.18. Rest of LATAM COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
7.6.19. Rest of LATAM COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
7.6.20. Rest of LATAM COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
7.7. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa COVID-19 Diagnostics Market Outlook, 2020-2033
8.1. Middle East & Africa COVID-19 Diagnostics Market Outlook, by Product, Value (US$ Mn), 2020-2033
8.1.1. Instruments
8.1.2. Reagents & Kits
8.2. Middle East & Africa COVID-19 Diagnostics Market Outlook, by Technology, Value (US$ Mn), 2020-2033
8.2.1. Polymerase Chain Reaction (PCR)
8.2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
8.2.3. Lateral Flow Immunoassay (LFIA)
8.2.4. Others
8.3. Middle East & Africa COVID-19 Diagnostics Market Outlook, by Sample Type, Value (US$ Mn), 2020-2033
8.3.1. Oropharyngeal & Nasopharyngeal Swabs
8.3.2. Nasal Swabs
8.3.3. Blood
8.4. Middle East & Africa COVID-19 Diagnostics Market Outlook, by Setting, Value (US$ Mn), 2020-2033
8.4.1. Lab-based
8.4.2. Point of Care
8.5. Middle East & Africa COVID-19 Diagnostics Market Outlook, by End-user, Value (US$ Mn), 2020-2033
8.5.1. Hospitals & Clinics
8.5.2. Laboratories & Diagnostic Centers
8.5.3. Home Testing
8.5.4. Others
8.6. Middle East & Africa COVID-19 Diagnostics Market Outlook, by Country, Value (US$ Mn), 2020-2033
8.6.1. GCC COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
8.6.2. GCC COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
8.6.3. GCC COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
8.6.4. GCC COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
8.6.5. GCC COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
8.6.6. South Africa COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
8.6.7. South Africa COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
8.6.8. South Africa COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
8.6.9. South Africa COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
8.6.10. South Africa COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
8.6.11. Egypt COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
8.6.12. Egypt COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
8.6.13. Egypt COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
8.6.14. Egypt COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
8.6.15. Egypt COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
8.6.16. Nigeria COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
8.6.17. Nigeria COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
8.6.18. Nigeria COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
8.6.19. Nigeria COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
8.6.20. Nigeria COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
8.6.21. Rest of Middle East COVID-19 Diagnostics Market Outlook, by Product, 2020-2033
8.6.22. Rest of Middle East COVID-19 Diagnostics Market Outlook, by Technology, 2020-2033
8.6.23. Rest of Middle East COVID-19 Diagnostics Market Outlook, by Sample Type, 2020-2033
8.6.24. Rest of Middle East COVID-19 Diagnostics Market Outlook, by Setting, 2020-2033
8.6.25. Rest of Middle East COVID-19 Diagnostics Market Outlook, by End-user, 2020-2033
8.7. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Vs Segment Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Abbott Laboratories
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Developments
9.4.2. Thermo Fisher Scientific Inc.
9.4.3. Roche Diagnostics (F. Hoffmann-La Roche Ltd.)
9.4.4. Siemens Healthineers AG
9.4.5. Danaher Corporation (including Beckman Coulter)
9.4.6. Bio-Rad Laboratories, Inc.
9.4.7. QuidelOrtho Corporation
9.4.8. Becton, Dickinson and Company (BD)
9.4.9. PerkinElmer, Inc.
9.4.10. Hologic, Inc.
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations